EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Biosimilars for anti-VEGF treatment of macular diseases: country and region reports

Miriam Cano, Mangala Dhanapala, Mengtian Kang, Mapa Prabhath Piyasena, Rajiv Raman, David Yorston

Community Eye Health Journal · 29.01.2025 · 37 (125)

DOI: 10.56920/cehj.835 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Community Eye Health Journal, online erschienen am 29.01.2025. Verfasst von Miriam Cano und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Cano, M., Dhanapala, M., Kang, M., Piyasena, M. P., Raman, R., & Yorston, D. (2025). Biosimilars for anti-VEGF treatment of macular diseases: country and region reports. Community Eye Health Journal, 37(125). https://doi.org/10.56920/cehj.835

Vancouver

Cano M, Dhanapala M, Kang M, Piyasena MP, Raman R, Yorston D. Biosimilars for anti-VEGF treatment of macular diseases: country and region reports. Community Eye Health Journal. 2025;37(125). doi:10.56920/cehj.835

BibTeX
@article{Cano2025,
  author = {Cano, Miriam and Dhanapala, Mangala and Kang, Mengtian and Piyasena, Mapa Prabhath and Raman, Rajiv and Yorston, David},
  title = {Biosimilars for anti-VEGF treatment of macular diseases: country and region reports},
  journal = {Community Eye Health Journal},
  year = {2025},
  volume = {37},
  number = {125},
  doi = {10.56920/cehj.835}
}
Kostenlos starten →